HSBC/CALL/AMGEN/300/0.1/15.01.25 | Market Closed - Bid/Ask 15:37:27 2024-07-15 EDT | After market 15:59:55 | |||
| 4.41 EUR | -2.86% |
|
4.375 | -0.79% |
| Current month | +37.58% | ||
| 1 month | +68.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-15 | 4.41 | -2.86% |
| 24-07-12 | 4.54 | +10.73% |
| 24-07-11 | 4.1 | +9.33% |
| 24-07-10 | 3.75 | +10.29% |
| 24-07-09 | 3.4 | +6.25% |
Real-time BOERSE MUENCHEN
Last update July 15, 2024 at 03:37 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HG8K75 |
| ISIN | DE000HG8K750 |
| Date issued | 2023-02-28 |
| Strike | 300 $ |
| Maturity | 2025-01-15 (184 Days) |
| Parity | 10 : 1 |
| Emission price | 1.3 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.77 € |
|---|---|
| Lowest since issue | 0.44 € |
| Spread | 0.03 € |
| Spread % | 0.67% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.8
USD
Average target price
317.4
USD
Spread / Average Target
-4.06%
- Stock Market
- Warrants
- Warrant
